|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | B01D 15/04 | (2006.01) |
| B01J 41/20 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 1/18 | (2006.01) | ||
| B01J 41/14 | (2006.01) | ||
| A61K 47/68 | (2017.01) |
| (11) | Number of the document | 3434346 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18174165.3 |
| Date of filing the European patent application | 2011-07-27 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation | 2020-12-28 |
| (30) | Number | Date | Country code |
| 36914810 P | 2010-07-30 | US |
| (72) |
LINKE, Thomas, US
WANG, William, K, US
SHAH, Ambarish, US
SATHISH, Hasige, US
HUNTER, Alan, US
THOMPSON, Christopher, US
|
| (73) |
MEDIMMUNE LIMITED,
Milstein Building Granta Park, Cambridge Cambridgeshire CB21 6GH,
GB
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Išgryninti veiklūs polipeptidai ar imunokonjugatai |
| PURIFIED ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES |
| Payment date | Validity (years) | Amount | |
| 2022-07-22 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-07-27 |